Cargando…
Synthesis and Structure–Activity Relationship Studies of Small Molecule Disruptors of EWS-FLI1 Interactions in Ewing’s Sarcoma
[Image: see text] EWS-FLI1 is an oncogenic fusion protein implicated in the development of Ewing’s sarcoma family tumors (ESFT). Using our previously reported lead compound 2 (YK-4-279), we designed and synthesized a focused library of analogues. The functional inhibition of the analogues was measur...
Autores principales: | Tosso, Perrer N., Kong, Yali, Scher, Lauren, Cummins, Ryan, Schneider, Jeffrey, Rahim, Said, Holman, K. Travis, Toretsky, Jeffrey, Wang, Kan, Üren, Aykut, Brown, Milton L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4281097/ https://www.ncbi.nlm.nih.gov/pubmed/25432018 http://dx.doi.org/10.1021/jm501372p |
Ejemplares similares
-
Small molecule selected to disrupt oncogenic protein EWS-FLI1 interaction with RNA Helicase A inhibits Ewing's Sarcoma
por: Erkizan, Hayriye V., et al.
Publicado: (2009) -
Pharmacokinetic modeling optimizes inhibition of the ‘undruggable’ EWS-FLI1 transcription factor in Ewing Sarcoma
por: Hong, Sung-Hyeok, et al.
Publicado: (2013) -
Single Enantiomer of YK-4-279 Demonstrates Specificity in Targeting the Oncogene EWS-FLI1
por: Barber-Rotenberg, Julie S., et al.
Publicado: (2012) -
High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition
por: Awad, Ola, et al.
Publicado: (2010) -
Acetylation Increases EWS-FLI1 DNA Binding and Transcriptional Activity
por: Schlottmann, Silke, et al.
Publicado: (2012)